The regular use of aspirin is associated with a slower progression of prostate cancer, according to a new study. It also showed that aspirin use may help in reducing the risk of dying from this malignant tumour.
According to the lead researcher, Dr. Christopher Allard, he and his team found that regular aspirin intake could decrease the risk of prostate cancer death by 40 percent. Then again, he said that it’s still premature to recommend it for the prevention of prostate cancer.
However, men with this condition who are already taking and benefiting from said drug could have another reason to regularly use aspirin.
During the Genitourinary Cancers Symposium in San Francisco, Dr. Allard said that men with this condition and are taking aspirin regularly had 39% lower risk of dying from this disease. But he added that it didn’t reduce the overall incidence of this disease and prevent high-grade or advanced prostate cancers. He also reported that aspirin intake before the diagnosis wasn’t beneficial.
There were several studies that already looked at the benefits of aspirin use in prostate cancer cases. But they have produced mixed results. Last year, a larger study was conducted in the UK and it was shown that aspirin use did not lower the overall mortality. However, in an earlier study, it showed that the drug could reduce the risk of dying from this disease from 10% to 4%.
The researchers, however, didn’t indicate the right dose of aspirin to derive the most benefit. It’s also important to remember that aspirin is a drug that can have negative effects, like bleeding.
Men who were diagnosed with this cancer but failed to heal through a curative treatment could benefit from rest, exercise, and eating leafy green vegetables and fruit. Plus, they must also eat less red meat.
Image Source: City of Hope